Mylan N.V.(NASDAQ: MYL
) shares were also up, gaining 14% to $21.10 after the company announced a business combination with Pfizer's Upjohn division.
: Disinvestment through KSE will provide more transparency to the ongoing exercise and will generate a lot of interest in broadbasing the ownership of equity.
The Standard's IFS rating could be upgraded one notch above MYL
's IFS rating if its standalone credit profile improved to 'A+'.
Wells Fargo analyst David Maris said he believes the EpiPen generic seemed to have been thought of as a 2019 event by Mylan (MYL
) and Teva (TEVA) investors, so the FDA approval today of the first generic EpiPen came earlier than expectations, which is both good news for Teva and negative news for Mylan.
) (TASE: MYL
) for SEK 165 per share (USD 7.2bn), the company said.
On March 7, 2016, SFG was acquired by Japan-based Meiji Yasuda Life Insurance Company (MYL
) (TASE: MYL
) to close its SEK 165 per share (USD 7.2bn) offer for Swedish drugmaker Meda Aktiebolag, the company said.
TLI has a strategic partnership with Meiji Yasuda Life Insurance Company (MYL
; IFS: A/Stable), which includes MYL
owning 15% of TLI.
Aviation Planning Services: In addition to those projects listed below which may require aviation planning services, MYL
may utilize the selected consultant for any of those items listed under paragraph 1.4.
Tickers featured: ABT, CAG, FCX, KFT, LO, MO, Mon, MYL
, PM, TMO, WMT.
ALSO LOWER: Mylan (MYL
) down 4.9% after FDA disclosure of Advair Diskus deficiencies...
Global pharmaceutical company Mylan NV (NASDAQ:MYL) (TASE: MYL
) and its Dutch partner, Synthon, have received marketing authorisation approval in Europe for Glatiramer Acetate Injection 40 mg/mL, the companies confirmed on Friday.